Current Early Detection Guidelines

One day there may be a single method for the earlydetection of breast cancer. Until then, using a com-bination of methods will increase your chances ofdetecting cancer in an early stage. These methodsinclude :

• Annual DITI screening for women of all ages.

• Mammography, when considered appropriatefor women who are aged 50 or older.

• A regular breast examination by a health professional.

• Monthly breast self-examination.

• Personal awareness for changes in the breasts.

• Readiness to discuss quickly any such changeswith a doctor.

These guidelines should be considered along withyour background and medical history.

DITI’s role in breast cancer and otherbreast disorders is to help in earlydetection and monitoring of abnormalphysiology and the establishment ofrisk factors for the development orexistence of cancer. When used withother procedures the best possibleevaluation of breast health is made.

“Early Detection Saves Lives”

Meditherm DITIAn extremely valuable test to help in the early detection of breast disease.

© Copyright Meditherm Inc. 2003

DITI has been recognized as a viable diagnostic tool since 1987 by theAMA Council on Scientific Affairs, the ACA Council on DiagnosticImaging, the Congress of Neuro-Surgeons in 1988 and in 1990 by theAmerican Academy of Physical Medicine and Rehabilitation.

www.meditherm.com/breasthealth

For information and appointments please contact:

Your results are reported quickly by certified doctors and include all color imagestaken during your test.

Increase your chances ofdetecting breast cancer in

its earliest stages.

WHO?

All women can benefit from DITI breastscreening. However, it is especially appropriatefor younger women (30 - 50) whose denserbreast tissue makes it more difficult formammography to be effective. Also for womenof all ages who, for many reasons, are unableto undergo routine mammography. This testcan provide a 'clinical marker' to the doctoror mammographer that a specific area of thebreast needs particularly close examination.

It takes years for a tumor to grow thus theearliest possible indication of abnormality isneeded to allow for the earliest possible treat-ment and intervention. DITI’s role in monitoringbreast health is to help in early detection andmonitoring of abnormal physiology.

Digital Infrared Thermal Imaging ‘DITI’ is a15 minute non invasive test of physiology. It isa valuable procedure for alerting your doctorto changes that can indicate early stage breastdisease.

The benefit of DITI testing is that it offersthe opportunity of earlier detection of breastdisease than has been possible throughbreast self examination, doctor examination ormammography alone.

DITI detects the subtle physiologic changesthat accompany breast pathology, whether it iscancer, fibrocystic disease, an infection or avascular disease. Your doctor can then planaccordingly and lay out a careful program tofurther diagnose and /or MONITOR you duringand after any treatment.

This quick and easy test starts with your medicalhistory being taken before you partially disrobefor the scanning to be performed. This first sessionprovides the baseline of your “thermal signature”.A subsequent session assures that the patternsremain unchanged.

All of your thermograms (breast images) arekept on record and once your stable thermalpattern has been established any changes canbe detected during your routine annual studies.

• Non invasive

• No radiation

• Painless

• No contact withthe body

• F.D.A approved

What is DITI? PROCEDURE

BASELINEBaseline thermogram showed aslight hyperthermic asymmetry in the upper right breast.

3 MONTHSThe follow-up study at 3 monthsshowed the pattern had becomemore well defined. Mammographywas inconclusive.

12 MONTHSSignificantly increased vascularchanges. Repeat mammogramshowed a small calcification (1 mm)at 1 O’clock. A lumpectomy wasperformed confirming a malignantcarcinoma (DCIS).

NORMALGood thermal symmetrywith no suspicious thermalfindings.These patterns represent abaseline that won’t alterover time and can only bechanged by pathology.

FIBROCYSTICSignificant vascular activityin the left breast which wasclinically correlated with fibrocystic changes.

INFLAMMATORY CANCERThere were no visible signs ofabnormality. Referral to a breast specialist and a subsequent biopsy diagnosedinflammatory breast cancer at a very early stage.

DUCTAL CARCINOMAThe vascular asymmetry in the upper left breast was particularly suspicious and clinical investigation indicated a palpable mass. A biopsy wasperformed and a DCIS of 2 cmwas diagnosed.